Flush financial research novel coronavirus pneumonia, August 11th, investors asked North China pharmaceutical company. Have you half a year passed Toxic Apis for Injection’s trial to treat new crown pneumonia?
the company replied that bee venom for injection (0.5mg freeze-dried powder injection) is a multi-component biochemical drug, and its indication is to treat rheumatoid arthritis, rheumatoid arthritis, peripheral neuritis and neuralgia, belonging to rheumatic arthralgia. The product was launched in early 2018, and its revenue accounted for less than 0.01% in 2019, with a small scale. Novel coronavirus pneumonia was first identified as novel coronavirus pneumonia prevention and control emergency research project in February 2020 by the provincial science and technology department.